 ANI Pharmaceuticals NASDAQ:ANIP had its price target cut by investment analysts at Raymond James from 49.00 to 40.00 in a research report issued to clients and investors on Monday, AnalystRatings.com reports. The brokerage currently has an outperform rating on the specialty pharmaceutical companys stock. Raymond James price target would indicate a potential upside of 29.41 ... 